Cargando…
Cdc7 is a potent anti-cancer target in pancreatic cancer due to abrogation of the DNA origin activation checkpoint
PURPOSE: Cdc7 is a serine/threonine kinase which is responsible for the ‘firing’ of replication origins leading to initiation of DNA replication. Inhibition or depletion of Cdc7 in normal cells triggers a DNA origin activation checkpoint causing a reversible G1 arrest. Here we investigate Cdc7 as a...
Autores principales: | Huggett, Matthew T., Tudzarova, Slavica, Proctor, Ian, Loddo, Marco, Keane, Margaret G., Stoeber, Kai, Williams, Gareth H., Pereira, Stephen P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951304/ https://www.ncbi.nlm.nih.gov/pubmed/26921250 http://dx.doi.org/10.18632/oncotarget.7611 |
Ejemplares similares
-
Targeting DNA replication before it starts: Cdc7 as a therapeutic target in p53 mutant Her2 and triple negative breast cancer
por: Sainsbury, R, et al.
Publicado: (2010) -
p53 controls CDC7 levels to reinforce G1 cell cycle arrest upon genotoxic stress
por: Tudzarova, Slavica, et al.
Publicado: (2016) -
The double trouble of metabolic diseases: the diabetes–cancer link
por: Tudzarova, Slavica, et al.
Publicado: (2015) -
G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer
por: Bucher, N, et al.
Publicado: (2008) -
Cdc6 contributes to abrogating the G1 checkpoint under hypoxic conditions in HPV E7 expressing cells
por: Chen, Hanxiang, et al.
Publicado: (2017)